Cardiol Therapeutics Inc. (CRDL.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 113.96M |
| Enterprise Value | 92.66M |
| P/E Ratio | -3.87 |
| PEG Ratio | -0.19 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.82 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.17 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.16 |
| Return On Equity | -2.29 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -101,983 |
| EBITDA | -34.21M |
| Net Income | -33.82M |
| Diluted EPS | -0.39 |
Balance Sheet
| Total Cash | 27.67M |
| Total Cash/Share | 0.25 |
| Total Debt | 116,408 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.39 |
| Book Value Per Share | 0.22 |
Price History
| 52-Week Change | -13.43 |
| 52-Week High | 2.33 |
| 52-Week Low | 1.23 |
| Moving Average 50 Days | 1.76 |
| Moving Average 200 Days | 1.54 |
Statistics
| Average Volume | 111,192 |
| Shares Outstanding | 115.27M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
